Trial site
Synexus Polska Sp. z o.o.
- 23running trials
- 13closed trials
The trials here
What the 36 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)6 trials
- Crohn's disease6 trials
- Obesity5 trials
- Psoriasis5 trials
- Fatty liver disease (MASLD/MASH)3 trials
- Type 2 diabetes3 trials
- Ulcerative colitis3 trials
- Chronic kidney disease2 trials
- Chronic spontaneous urticaria1 trial
- Coeliac disease1 trial
- Eosinophilic oesophagitis1 trial
- Heart failure1 trial
- and 4 more
- Phase
- Phase 323 trials
- Phase 211 trials
- Phase 2/32 trials
- Status
- Active, not recruiting15 trials
- Completed12 trials
- Recruiting7 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Bristol-Myers Squibb3 trials
- Pfizer3 trials
- Sanofi3 trials
- Akero Therapeutics Inc.2 trials
- Ascletis Pharma (China) Co. Ltd.2 trials
- and 21 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Terminated
Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
Terminated
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Obesity2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Coeliac disease1 recruiting
- Heart failure1 recruiting
- Psoriasis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Recruiting
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Completed
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Terminated
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026